Madam Chair, we know that during this unprecedented time of coronavirus, the entire world has turned its attention to drugs that will help treat this disease. We know that it's a challenging time for drug manufacturers as well, as they search for a cure to COVID-19.
Certainly we're keeping our eye on the applications to Canada and we are working to ensure that Canadians will always have access to the drugs that they need and deserve.